NYSVMS is hosting the Controlled Substances webinar Part 1-Compliance checkup: A DEA health assessment for your veterinary practice on March 17th from 7-8 PM presented by: Courtney VanDoren. This interactive webinar provides veterinary professionals with a structured approach to assessing and improving their practice’s DEA compliance. Participants will learn to evaluate their current compliance status using a “compliance health” framework, covering key areas such as regulatory research, self-assessment, immediate action steps, and preventive strategies. The session includes guidance on utilizing compliance checklists and health score charts, along with a mock exam of a sample hospital to illustrate practical application. The goal is to equip attendees with actionable steps to achieve and maintain optimal DEA compliance.

continue reading


CVM marks a decade of innovation at the Animal Health Hackathon

On Feb 20-22, the Cornell University College of Veterinary Medicine (CVM) celebrated the tenth anniversary of its Animal Health Hackathon. The signature interdisciplinary event gathered over 100 students from across Cornell’s colleges to compete in a time-honored challenge that has grown from a small campus experiment into a leading student‑run engine for veterinary and animal health innovations.

continue reading


Landmark study finds striking parallels in feline, human cancers

A groundbreaking study from an international team of experts in veterinary medicine, human medicine and genomics provides the first large-scale genetic map of feline cancer, revealing that cats may hold the key to understanding several human cancers. The study,published Feb. 19 in Science , identified key similarities between certain oncogenes – the class of genes whose mutations cause cancer – in the feline cancers studied and their homologous counterparts in humans.

continue reading


Cornell University Hospital for Animals enrolling cats with CKD IRIS into diet trial   

Cornell University Hospital for Animals is now enrolling cats with CKD IRIS stages 1 or 2 into a 12 month diet trial. Animal Medical Center in Manhattan is also enrolling patients in the study. The diet is optimized for GI health and phosphorous restriction. Since many uremic toxins originate in the gut, and the kidney and gut decline in synchrony in middle aged to older cats, the idea is to modulate microbial health and metabolism while restricting PO4. This is a randomized, prospective, blinded clinical trial. Clients are provided 12 months of canned food for free from the company. There are 5 visits required (one every 3 months), and the owners are asked to fill out a monthly electronic survey. Inclusion: Ages 2-16 years, CKD Stage 1 or 2 based on IRIS Staging: Stage 1: Persistent SDMA > 14 ug/dL, abnormal kidney imaging, or persistent UPC > 0.4, Stage 2: Serum creatinine >/= 1.6 mg/dL OR SDMA > 14 ug/dL with a USG < 1.035, Good general health based on physical exam and laboratory analyses, BCS 2/5 or greater, Normal appetite. Exclusion: FIV, FeLV, FIP, Hepatic or biliary disease, Diabetes mellitus, Hyperthyroidism (unless treated and stable with I-131 therapy), Confirmed neoplasia (exception: alimentary small cell lymphoma). Please contact vet-research@cornell.edu for any questions or to refer patients!


Updated guidance on canine chronic inflammatory enteropathy discourages antibiotic use, encourages dietary trials

As research has advanced understanding of chronic gastrointestinal (GI) inflammation in dogs, the American College of Veterinary Internal Medicine (ACVIM) has endorsed a new consensus statement on the diagnosis and treatment of chronic inflammatory enteropathy (CIE) in dogs. The consensus statement, published on January 21, outlines a stepwise diagnostic approach, that includes patient history, clinical signs, physical examination findings, sequential diagnostic tests, and imaging. It also covers practical treatment strategies for managing CIE that tailor care based on a patient’s underlying disease subtype and response to therapy.

continue reading


Highly pathogenic avian influenza continues to spread in Pennsylvania poultry operations

DVM360

Highly pathogenic avian influenza (HPAI) continues to impact commercial poultry facilities in Pennsylvania, prompting state and federal officials to expand response and surveillance efforts. According to the Pennsylvania Department of Agriculture, the state has seen a recent increase in infections among poultry flocks, leading officials to mobilize additional personnel, increase testing capacity, and coordinate response activities with federal partners including the US Department of Agriculture (USDA). The move is intended to protect the state’s poultry industry and help contain further spread of the virus.

continue reading


Are frequent joint injections safe for horses?

The Horse

My reining horse receives steroid hock injections approximately every six months. I also receive joint injections, but my doctor is reluctant to do them too frequently. If they aren’t good for me, are they good for my horse? Are there other options to manage his joint health?

continue reading